Elizabeth Neeley v. HHS - Tdap, Guillain-Barré Syndrome (2017)

Elizabeth Neeley filed a petition for compensation under the National Vaccine Injury Compensation Program on February 23, 2016, alleging that she developed Guillain-Barré Syndrome (GBS) and/or other neurological and physical impairments following vaccinations she received on or about February 20, 2015. The vaccines in question were the haemophilus influenzae type B (Hib), hepatitis A, hepatitis B, and tetanus-diphtheria-acellular pertussis (TDaP).

The parties, Elizabeth Neeley and the Secretary of Health and Human Services, filed a joint stipulation on July 19, 2017, agreeing to settle the case. While the respondent denied that the vaccines caused Ms.

Neeley's GBS or any other injury, they agreed to an award of compensation. Under the terms of the stipulation, Ms.

Neeley was to receive a lump sum of $132,656.35 for first-year life care expenses, pain and suffering, and past unreimbursable expenses. Additionally, an amount sufficient to purchase an annuity contract was to be paid to a life insurance company for her benefit, covering future expenses such as Medigap, medical equipment, and attendant care.

The case proceeded as a Table claim, as GBS is listed on the Vaccine Injury Table. The decision adopted the stipulation as the court's decision, awarding compensation and releasing the United States from further liability related to these vaccinations.